NCT04471116 is a NA clinical trial of OMNi-BiOTiC® FLORA plus+ in Vaginal Microbiome, sponsored by Kinderwunsch Institut GmbH.

Who is sponsoring NCT04471116?

NCT04471116 is sponsored by Kinderwunsch Institut GmbH.

What drugs are being tested in NCT04471116?

Interventions in NCT04471116: OMNi-BiOTiC® FLORA plus+.

What condition does NCT04471116 study?

NCT04471116 studies Vaginal Microbiome.

Is NCT04471116 still recruiting?

NCT04471116 is currently completed. Last updated 16 July 2020.

Last reviewed 2020-07-16 · How we verify

NCT04471116

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Probiotics on the Vaginal Microbiota

Completed NA Last updated 16 July 2020

What this trial tests

NA trial testing OMNi-BiOTiC® FLORA plus+ in Vaginal Microbiome in 80 participants. Completed in 12 November 2019.

Timeline

30 March 2018

Primary endpoint
19 July 2019

12 November 2019

Quick facts

Lead sponsor	Kinderwunsch Institut GmbH
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	80
Start date	30 March 2018
Primary completion	19 July 2019
Estimated completion	12 November 2019
Sites	1 location across Austria

Drugs / interventions tested

OMNi-BiOTiC® FLORA plus+

Conditions studied

Vaginal Microbiome — all drugs for Vaginal Microbiome →

Sponsor

Kinderwunsch Institut GmbH

Who can join

Adults 18 to 40, female only, with Vaginal Microbiome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to assess the influence of a probiotic supplement (OMNi-BiOTiC® FLORA plus +) on the vaginal microbiome composition of women suffering from infertility.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of OMNi-BiOTiC® FLORA plus+

Trials testing the same drug.

NCT06888518 — Multistrain Probiotics Against Bacterial Vaginosis · EARLY_PHASE1 · terminated

Other recruiting trials for Vaginal Microbiome

Currently open trials in the same condition.

NCT07109713 — The Effect Cranberry-Based Products on the Female Microbiome · NA · recruiting
NCT06912126 — The Maggie Project: Exploring the Origin and Heredity of the Vaginal Microbiome · recruiting
NCT06643065 — The Influence of the Vaginal Microbiome on Clinical Pregnancy in Patients Undergoing a Euploid Embryo Transfer: a Prospe · recruiting
NCT06356012 — Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod · Phase 4 · recruiting
NCT05666778 — Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs · Phase 2 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04471116 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kinderwunsch Institut GmbH
Last refreshed: 16 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04471116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing